APPLE Academy is a prestigious educational initiative by the Asia-Pacific Primary Liver Cancer Expert Association (APPLE), designed to nurture the next generation of liver cancer experts.
This intensive program brings together young clinicians and researchers from across the Asia-Pacific region for in-depth learning, case discussions, and networking with world-renowned faculty in the field of liver cancer.
With strong support from leading industry partners, APPLE Academy offers a unique platform to share real-world clinical insights, explore the latest advancements, and build long-lasting professional collaborations.
Friday, July 3, 2026
09:50-10:00
Opening Remark
Pierce Chow (Singapore)
SESSION 1: CHANGES IN THE LANDSCAPE OF HCC
Pierce Chow, Ying-Hong Shi
10:00-10:25
Changing Etiology and Epidemiology of HCC in Asia: Practical Implications
Do Young Kim (Seoul)
10:25-10:50
Management of HCC in the Asia-Pacific Region: How Real-World Data Can Help
Bo Hyun Kim (Goyang)
10:50-11:15
What the BCLC CUSE Framework Means to Asia HCC Patients and Their Doctors
Han-Chong Toh (Singapore)
11:15-11:30
Discussion
11:30-13:00
Luncheon and Networking
SESSION 2: IMPROVING CURE AND SURVIVAL FOR INTERMEDIATE/ADVANCED STAGE HCC
Moon Seok Choi, Yi-Hsiang Huang
13:00-13:25
Downstaging Approaches to Improve Curability
Hui-Chuan Sun (Shanghai)
13:25-13:50
Roles of Different Liver-Directed Interventions (TACE, TARE, Ablation, etc.)
Guo-Hong Han (Xi' An)
13:50-14:15
Integrating Systemic and Liver-Directed Therapy: Oncologist's Perspective
Thomas Yau (Hong Kong)
14:15-14:30
Discussion
14:30-14:50
Coffee Break
SESSION 3: BUILDING INTERNATIONAL COLLABORATION
Pierce Chow, Chiun Hsu
14:50-15:15
Clinical Research
Kaina Chen (Singapore)
15:15-15:40
Translational Research
Ying-Chun Shen (Taipei)
15:40-16:05
Networking Opportunities and Challenges
Stephen L. Chan (Hong Kong)
16:05-16:20
Discussion
16:20-16:30
Closing Remark
Jian Zhou (Shanghai)
The APPLE Academy receives sponsorship from Eisai.
